Luciole Medical AG, a Swiss medical technology company, announced on June 27 that it acquired Spiegelberg GmbH & Co. KG from SHS Capital. According to data captured in the LevinPro HC database, this transaction represents the 64th Medical Devices transaction of 2023.
Spiegelberg develops, produces and distributes products for intracranial pressure measurement, cerebrospinal fluid drainage and IAP measurement in more than sixty countries. The company is based in Hamburg, Germany.
SHS Capital is a private equity firm in Tübingen, Germany. It has approximately $272 million in assets under management.
Luciole Medical AG is developing a unique next-generation platform of brain monitoring sensors to rapidly provide important information allowing the proper diagnosis and monitoring of compromised oxygen supply conditions and complications.
Following the acquisition, Luciole Medical and Spiegelberg will combine product suites, manufacturing and distribution channels to optimize strengths, aiming to become a global leader in providing innovative next-generation brain monitoring devices. The financial terms of the acquisition were not disclosed.
